Skip to content
2000
Volume 26, Issue 3
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Introduction

Routine synthetic chemo-drugs for the treatment of glioma exhibit limited blood-brain barrier (BBB) permeation and unavoidable serious neuronal toxicity with substandard treatment outcomes, which necessitates the exploration of novel, efficacious yet healthy tissue-friendly entities having the desired physicochemical characteristics with effective anticancer potential.

Methods

ADMET analysis to investigate drug-likeness and toxicity profile of alpha-terpineol, followed by characterization of selected proteins. studies, such as molecular docking and molecular simulation studies, were employed. Further, to validate the results, an MTT assay and an in-vitro antioxidant study were carried out.

Results

ADMET analysis showed promising results. Alpha-terpineol docked preferentially with selected glioma proliferation proteins, having a good docking score (>8). Reasonable antioxidant and cytotoxicity activity (IC 18.3±1.1 µg/ml) was observed from DPPH and MTT assays .

Discussion

The present study confirmed the potential anti-inflammatory, antioxidant, and anticancer effects of AT, which were further supported by study results. ADME analysis showed favourable drug-likeness of AT with desirable BBB permeation characteristics. AT was found to be potentially toxic to C6 glioma cells, whereas negligibly toxic to healthy neuronal cells.

Conclusion

The outcomes of the study provide supportive evidence to proceed with further testing of AT in glioma models to establish it as a potent, efficacious anticancer drug.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266386465250702204827
2025-07-18
2026-03-10
Loading full text...

Full text loading...

References

  1. SinghA.V. VarmaM. RaiM. Pratap SinghS. BansodG. LauxP. LuchA. Advancing Predictive Risk Assessment of Chemicals via Integrating Machine Learning, Computational Modeling, and Chemical/Nano‐Quantitative Structure‐Activity Relationship Approaches.Adv. Intell. Syst.202464230036610.1002/aisy.202300366
    [Google Scholar]
  2. SharmaP. RanjanP. ChakrabortyT. Applications of conceptual density functional theory in reference to quantitative structure–activity/property relationship.Mol. Phys.202412223e233162010.1080/00268976.2024.2331620
    [Google Scholar]
  3. Chunarkar-PatilP. KaleemM. MishraR. RayS. AhmadA. VermaD. BhayyeS. DubeyR. SinghH. KumarS. Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies.Biomedicines202412120110.3390/biomedicines12010201 38255306
    [Google Scholar]
  4. JawarkarR.D. ZakiM.E.A. Al-HussainS.A. Al-MutairiA.A. SamadA. MasandV. HumaneV. MaliS. AlzahraniA.Y.A. RashidS. ElossailyG.M. Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in-vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor.J. Biomol. Struct. Dyn.202413110.1080/07391102.2024.2319104 38385447
    [Google Scholar]
  5. Al-ThaniA.N. JanA.G. AbbasM. GeethaM. SadasivuniK.K. Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review.Life Sci.202435212289910.1016/j.lfs.2024.122899 38992574
    [Google Scholar]
  6. ObradorE. Moreno-MurcianoP. Oriol-CaballoM. López-BlanchR. PinedaB. Gutiérrez-ArroyoJ. LorasA. Gonzalez-BonetL. Martinez-CadenasC. EstrelaJ. Marqués-TorrejónM. Glioblastoma Therapy: Past, Present and Future.Int. J. Mol. Sci.2024255252910.3390/ijms25052529 38473776
    [Google Scholar]
  7. PöhlmannJ. WellerM. MarcellusiA. Grabe-HeyneK. Krott-CoiL. RabarS. PollockR.F. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.Front. Oncol.202414136860610.3389/fonc.2024.1368606 38571509
    [Google Scholar]
  8. GhaziB. HarmakZ. RghiouiM. KoneA.S. El GhanmiA. BadouA. Decoding the secret of extracellular vesicles in the immune tumor microenvironment of the glioblastoma: on the border of kingdoms.Front. Immunol.202415142323210.3389/fimmu.2024.1423232 39267734
    [Google Scholar]
  9. ChangC. ChavarroV.S. GerstlJ.V.E. BlitzS.E. SpanehlL. DubinskiD. ValdesP.A. TranL.N. GuptaS. EspositoL. MazzettiD. GesslerF.A. ArnaoutO. SmithT.R. FriedmanG.K. PeruzziP. BernstockJ.D. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms.Int. J. Mol. Sci.20242512673310.3390/ijms25126733 38928445
    [Google Scholar]
  10. NortonE.S. WhaleyL.A. JonesV.K. BrooksM.M. RussoM.N. MordererD. JessenE. SchiapparelliP. Ramos-FresnedoA. ZarcoN. CarranoA. RossollW. AsmannY.W. LamT.T. ChaichanaK.L. AnastasiadisP.Z. Quiñones-HinojosaA. Guerrero-CázaresH. Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.Sci. Adv.,20241032eadn160710.1126/sciadv.adn160739110807
    [Google Scholar]
  11. YoelA. AdjumainS. LiangY. DanielP. FiresteinR. TsuiV. Emerging and biological concepts in pediatric high-grade gliomas.Cells20241317149210.3390/cells13171492 39273062
    [Google Scholar]
  12. OnciulR. BreharF.M. ToaderC. Covache-BusuiocR.A. GlavanL.A. BratuB.G. CostinH.P. DumitrascuD.I. SerbanM. CiureaA.V. Deciphering glioblastoma: Fundamental and novel insights into the biology and therapeutic strategies of gliomas.Curr. Issues Mol. Biol.20244632402244310.3390/cimb46030153 38534769
    [Google Scholar]
  13. HanY.P. LinH.W. LiH. Cancer stem cells in tumours of the central nervous system in children: A comprehensive review.Cancers20231512315410.3390/cancers15123154 37370764
    [Google Scholar]
  14. JezierzańskiM. NafalskaN. StopyraM. FurgołT. MiciakM. KabutJ. Gisterek-GrocholskaI. Temozolomide (TMZ) in the treatment of glioblastoma multiforme—A literature review and clinical outcomes.Curr. Oncol.20243173994400210.3390/curroncol31070296 39057168
    [Google Scholar]
  15. HilalB. KhanM.M. FariduddinQ. Recent advancements in deciphering the therapeutic properties of plant secondary metabolites: Phenolics, terpenes, and alkaloids.Plant Physiol. Biochem.202421110867410.1016/j.plaphy.2024.108674 38705044
    [Google Scholar]
  16. KaushikA. KaushikM. KaurG. GuptaV. Perspective of secondary metabolites in respect of multidrug resistance (MDR): A review.Infect. Disord. Drug Targets2024244e22112322372210.2174/0118715265210606231113105225 38031773
    [Google Scholar]
  17. CuongN.M. KhanhP.N. NhungL.T.H. HaN.X. HuongT.T. BauerovaK. KimY.H. TungD.D. ThuyT.T. AnhN.T.H. Acetylcholinesterase inhibitory activities of some flavonoids from the root bark of Pinus krempfii Lecomte: In vitro and in silico study.J. Biomol. Struct. Dyn.20244294888490110.1080/07391102.2023.2223664 37325850
    [Google Scholar]
  18. PružinskáK. ChrastinaM. KhademnematolahiS. VyletelováV. GajdošováL. PastvováL. DráfiF. PoništS. PaškováĽ. KucharskáJ. SumbalováZ. MuchováJ. MartiniakováS. BauerováK. Astaxanthin, compared to other carotenoids, increases the efficacy of methotrexate in rat adjuvant arthritis.Int. J. Mol. Sci.20242516871010.3390/ijms25168710 39201397
    [Google Scholar]
  19. OmariN.E. ChamkhiI. BakrimS. AannizT. BenaliT. AkhazzaneM. UllahR. AlotaibiA. BariA. ElhrechH. ZenginG. BouyahyaA. Biological properties of Mentha viridis L. essential oil and its main monoterpene constituents.Chem. Biodivers.2024219e20240120910.1002/cbdv.202401209 38865194
    [Google Scholar]
  20. HegdeS.S. MalashettyV.B. Azoospermia and multi-organ damage in juvenile rats exposed to α-Terpineol from weaning to sexual maturity.Toxicol. Appl. Pharmacol.202449211710610.1016/j.taap.2024.117106 39278549
    [Google Scholar]
  21. NegreirosH.A. FonteleS.B.C. BatistaF.A. FariasM.G. SilvaF.C.C. NascimentoM.L.L.B. MouraK.G. CorreaL.S. PereiraA.R.S. LopesL.O. FerreiraP.M.P. MendesA.N. GonçalvesJ.C.R. Melo-CavalcanteA.A.C. SousaJ.M.C. Toxicogenetic profile of the monoterpene alpha-terpineol on normal and tumor eukaryotic cells.Drug Chem. Toxicol.202447442743510.1080/01480545.2023.2188440 36912194
    [Google Scholar]
  22. MechraouiI. MahfoudiR. DjeridaneA. YilmazM.A. YousfiM. Comparative chemical profiling and antioxidant properties of essential oils extracted from: Foeniculum vulgare subsp. piperitum (Ucria) Bég and Deverra scoparia Coss. &.Durieu. Biocatal Agric. Biotechnol.20246010330610.1016/j.bcab.2024.103306
    [Google Scholar]
  23. JameelF. IrfanF. SalimA. KhanI. KhalilE.A. Alpha terpineol preconditioning enhances regenerative potential of mesenchymal stem cells in full thickness acid burn wounds.Regen. Ther.20242618820210.1016/j.reth.2024.05.008 38948132
    [Google Scholar]
  24. PrernaC. ChadhaJ. KhullarL. MudgilU. HarjaiK. A comprehensive review on the pharmacological prospects of Terpinen-4-ol: From nature to medicine and beyond.Fitoterapia202417610605110.1016/j.fitote.2024.106051 38838826
    [Google Scholar]
  25. RautelaJ. RawatS. JakhmolaV. Advanced anticancer application of thymus zygis essential oil (EOT).Pharmacological Aspects of Essential Oils.Boca Raton, FLCRC Press202315316110.1201/9781003389774‑11
    [Google Scholar]
  26. JinJ.S. ChouJ.M. TsaiW.C. ChenY.C. ChenY. OngJ.R. TsaiY.L. Effectively α-terpineol suppresses glioblastoma aggressive behavior and downregulates KDELC2 expression.Phytomedicine202412715547110.1016/j.phymed.2024.155471 38452695
    [Google Scholar]
  27. YadavM. NarasimhanB. KapoorA. Development of 2-dimensional and 3-dimensional QSAR models of Indazole derivatives as TTK inhibitors having Anticancer potential.Curr. Chem. Lett202413122524010.5267/j.ccl.2023.6.006
    [Google Scholar]
  28. ŞahinS. 3,4-difluoro-2-(((4-phenoxyphenyl)imino)methyl)phenol with in silico predictions: Synthesis, spectral analyses, ADME studies, targets and biological activity, toxicity and adverse effects, site of metabolism, taste activity.J. Mol. Struct.2024131713913610.1016/j.molstruc.2024.139136
    [Google Scholar]
  29. MuktyS.A. HasanR. BhuiaM.S. SahaA.K. RahmanU.S. KhatunM.M. BithiS.A. AnsariS.A. AnsariI.A. IslamM.T. Assessment of sedative activity of fraxin: In vivo approach along with receptor binding affinity and molecular interaction with GABAergic system.Drug Dev. Res.2024856e2225010.1002/ddr.22250 39154218
    [Google Scholar]
  30. AdesinaA.F. AdewuyiA. OtuechereC.A. Exploratory studies on chrysin via antioxidant, antimicrobial, ADMET, PASS and molecular docking evaluations.Pharmacol. Res. Mod. Chin. Med.20241110041310.1016/j.prmcm.2024.100413
    [Google Scholar]
  31. RagabN.A. El ShabrawyM.O. FaridM.M. MarzoukM.M. Flavonoids from Pancratium aegyptiacum M. Roem.: Exploring the potential anti‐Alzheimer’s activity through network pharmacology and in silico analysis.ChemistrySelect2024926e20240092810.1002/slct.202400928
    [Google Scholar]
  32. FatemaK. SharnaJ.F. HaqueM.A. UzzamanM. KhatunR. JannatN. UddinJ. UddinM.N. KaziM. PatwaryM.A.M. In-vitro antioxidant and antidiabetic effects of Rorippa indica (L.) extract and fractions with molecular docking, dynamics simulation, ADMET, and PASS studies.J. Mol. Struct.2024131613886810.1016/j.molstruc.2024.138868
    [Google Scholar]
  33. GoswamiV. PatelD. RohitS. ChaubeU. PatelB. Homology modeling, binding site identification, molecular docking and molecular dynamics simulation study of emerging and promising drug target of Wnt signaling – Human Porcupine enzyme.Results Chem.2024710148210.1016/j.rechem.2024.101482
    [Google Scholar]
  34. SultanaT. MouS.I. ChatterjeeD. FarukM.O. HosenM.I. Computational exploration of SLC14A1 genetic variants through structure modeling, protein-ligand docking, and molecular dynamics simulation.Biochem. Biophys. Rep.20243810170310.1016/j.bbrep.2024.101703 38596408
    [Google Scholar]
  35. PandeyA. MishraS. PatraA. SomvanshiP. BhaveshN.S. ChaturvediR. Role of curcumin’s phenolic –OH group in the inhibition of Helicobacter pylori CagA phosphorylation.J. Mol. Struct.2024129613676310.1016/j.molstruc.2023.136763
    [Google Scholar]
  36. GomhaS.M. AbolibdaT.Z. AlruwailiA.H. FaragB. BoraieW.E. Al-HussainS.A. ZakiM.E.A. HusseinA.M. Efficient green synthesis of hydrazide derivatives using L-Proline: Structural characterization, anticancer activity, and molecular docking studies.Catalysts202414848910.3390/catal14080489
    [Google Scholar]
  37. BugnonM. RöhrigU.F. GoullieuxM. PerezM.A.S. DainaA. MichielinO. ZoeteV. SwissDock 2024: Major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina.Nucleic Acids Res.202452W1W324W33210.1093/nar/gkae300 38686803
    [Google Scholar]
  38. ColeD.J. Tirado-RivesJ. JorgensenW.L. Molecular dynamics and Monte Carlo simulations for protein–ligand binding and inhibitor design.Biochim. Biophys. Acta, Gen. Subj.20151850596697110.1016/j.bbagen.2014.08.018 25196360
    [Google Scholar]
  39. HarderE. DammW. MapleJ. WuC. ReboulM. XiangJ.Y. WangL. LupyanD. DahlgrenM.K. KnightJ.L. KausJ.W. CeruttiD.S. KrilovG. JorgensenW.L. AbelR. FriesnerR.A. OPLS3: A force field providing broad coverage of drug-like small molecules and proteins.J. Chem. Theory Comput.201612128129610.1021/acs.jctc.5b00864 26584231
    [Google Scholar]
  40. ShivakumarD. WilliamsJ. WuY. DammW. ShelleyJ. ShermanW. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field.J. Chem. Theory Comput.2010651509151910.1021/ct900587b 26615687
    [Google Scholar]
  41. JorgensenW.L. Tirado-RivesJ. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.J. Am. Chem. Soc.198811061657166610.1021/ja00214a001 27557051
    [Google Scholar]
  42. BettadjF.Z.Y. BenchoukW. GuendouziA. Computational exploration of novel ketoprofen derivatives: Molecular dynamics simulations and MM-PBSA calculations for COX-2 inhibition as promising anti-inflammatory drugs.Comput. Biol. Med.202418310920310.1016/j.compbiomed.2024.109203 39395347
    [Google Scholar]
  43. SaravananV. ChagaletiB.K. PackiapalavesamS.D. KathiravanM. Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX.RSC Advances20241453346335810.1039/D3RA08618F 38259989
    [Google Scholar]
  44. LiD.D. MaJ.R. HuangQ.R. ManR.J. ZhaoL. Exploring protein-berberine interactions via molecular dynamics and MM/GBSA calculations.J. Mol. Liq.202441112575510.1016/j.molliq.2024.125755
    [Google Scholar]
  45. BourichaE.M. HakmiM. Investigating lasofoxifene efficacy against the Y537S + F404V double-mutant estrogen receptor alpha using molecular dynamics simulations.Bioinform. Biol. Insights2024181177932224128870310.1177/11779322241288703 39386976
    [Google Scholar]
  46. FrancisR. KalyanaramanR. BoominathanV. ParthasarathyS. ChavaanA. AnsariI.A. AnsariS.A. AlkahtaniH.M. ChandranJ. TharumasivamS.V. Piperine’s potential in treating polycystic ovarian syndrome explored through in-silico docking.Sci. Rep.20241412183410.1038/s41598‑024‑72800‑6 39294254
    [Google Scholar]
  47. RehmanY.U. IqbalA. AliG. AlotaibiG. AhmedA. AyazM. Phytochemical analysis, radical scavenging and glioblastoma U87 cells toxicity studies of stem bark of buckthorn (Rhamnus pentapomica R. Parker).BMC Complement. Med. Ther.20242411210.1186/s12906‑023‑04309‑w 38167318
    [Google Scholar]
  48. BicasJ.L. Neri-NumaI.A. RuizA.L.T.G. De CarvalhoJ.E. PastoreG.M. Evaluation of the antioxidant and antiproliferative potential of bioflavors.Food Chem. Toxicol.20114971610161510.1016/j.fct.2011.04.012 21540069
    [Google Scholar]
  49. RoutS. SatapathyB.S. SahooR.N. PattnaikS. Telmisartan loaded lipid nanocarrier as a potential repurposing approach to treat glioma: Characterization, apoptosis evaluation in U87MG cells, pharmacokinetic and molecular simulation study.Nanotechnology2024354242510110.1088/1361‑6528/ad64e0 39025086
    [Google Scholar]
  50. RaufA. KhalilA.A. AwadallahS. KhanS.A. Abu-IzneidT. KamranM. HemegH.A. MubarakM.S. KhalidA. WilairatanaP. Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A review.Food Sci. Nutr.202412267569310.1002/fsn3.3784 38370049
    [Google Scholar]
  51. BauerovaK. AcquavivaA. PonistS. GardiC. VecchioD. DrafiF. ArezziniB. BezakovaL. KuncirovaV. MihalovaD. NosalR. Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination.Autoimmunity2015481465610.3109/08916934.2014.939268 25046647
    [Google Scholar]
  52. MafiA. KhoshnazarS.M. ShahparA. NabaviN. HedayatiN. AlimohammadiM. HashemiM. TaheriazamA. FarahaniN. Mechanistic insights into circRNA-mediated regulation of PI3K signaling pathway in glioma progression.Pathol. Res. Pract.202426015544210.1016/j.prp.2024.155442 38991456
    [Google Scholar]
  53. ChenX. AgustinusA.S. LiJ. DiBonaM. BakhoumS.F. Chromosomal instability as a driver of cancer progression.Nat. Rev. Genet.2024261314610.1038/s41576‑024‑00761‑7 39075192
    [Google Scholar]
  54. GardiC. BauerovaK. StringaB. KuncirovaV. SlovakL. PonistS. DrafiF. BezakovaL. TedescoI. AcquavivaA. BilottoS. RussoG.L. Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis.Arch. Biochem. Biophys.201558315015710.1016/j.abb.2015.08.008 26297952
    [Google Scholar]
  55. RogovskiiV. Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment.Front. Immunol.202415141645810.3389/fimmu.2024.1416458 39206193
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266386465250702204827
Loading
/content/journals/ctmc/10.2174/0115680266386465250702204827
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test